Medtronic (NYSE:MDT) CEO Omar Ishrak was on hand this week to cut the ribbon on the medical device giant’s 1st office in Bangladesh, where Ishrak grew up.
Emerging Markets
South Korea is a “key market” in Covidien’s global strategy
Saudi Arabia offers potential for medical device manufacturers
By Stewart Eisenhart, Emergo Group
For many outsiders, the Kingdom of Saudi Arabia (KSA) remains an enigma. Few Western medical device manufacturers understand the culture and often skip over the KSA to pursue other markets. But there are good reasons to pay attention to this growing market.
Russian regulators push back deadline for medical device registration reauthorizations
By Stewart Eisenhart, Emergo Group
Russian medical device regulators have decided to extend their deadline for requiring medical device manufacturers to obtain replacement registration certifications (links to webpage in Russian) from January 2014 to January 2017.
Emerging markets: MedTech heads to Africa
By Erin Warner
The large medtech companies talk endlessly about emerging markets delivering their top-line growth targets, and they are not just talking about BRIC countries anymore.
New rules for supplementary information requests in China
By Stewart Eisenhart, Emergo Group
Chinese medical device market regulators have enacted a new requirement regarding supplementary documentation requests (links to page in Chinese) related to registration with the China Food and Drug Administration (CFDA).
Effective June 1 2013, medical device registration applicants that receive CFDA requests for supplementary information must comply with the following rules:
Podcast: Medtronic CEO Omar Ishrak on emerging markets, economic value and the medtech tax
Covidien CEO Almeida wants more from emerging markets | Wall Street Beat
Medical device giant Covidien is doubling down on emerging markets, expanding an investment program that the company had, at one point, thought would be over by the end of 2013.
Premier Dx Health signs China vendor agreement with Siemens
Premier Diagnostic, a medical imaging and diagnostic company, signed a letter of intent with Siemens (NYSE:SI) to distribute imaging devices in China. The agreement will provide Premier with lease financing for MRI and PET/CT equipment to open another Center for Advanced Diagnostics in the People’s Republic.
Boston Scientific’s 5-part recipe for success
Medical device giant Boston Scientific (NYSE:BSX) has been soaring in recent months, with BSX shares up more than 50% since the start of 2013.
ALung pursues Chinese approval for Hemolung
ALung Technologies said it’s pursuing approval from Chinese regulatory authorities for its Hemolung respiratory assist system.
The Pittsburgh-based medical device company said it inked a deal with Curative Medical to seek approval for the Hemolung device from the China Food & Drug Administration.